Case ReportJournal of Pharmacy Practice and Community MedicineVol. 12 | Issue 3 | 2026 | pp. 191–195Open access
A Case Reports On Bilateral Diffuse Cystic Lung Disease (Pulmonary Langerhans’ Cell Histiocytosis)
- 1,
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1
- 1 Department of Pharmacy Practice, Pharmacology, Nirmala College of Pharmacy, Acharya Nagarjuna University, Atmakur, Mangalagiri, Guntur, Andhra Pradesh, INDIA.
Published in Journal of Pharmacy Practice and Community Medicine
Correspondence: Snehitha Kasu
Department of Pharmacy Practice, Pharmacology, Nirmala College of Pharmacy, Acharya Nagarjuna University, Atmakur, Mangalagiri, Guntur, Andhra Pradesh, INDIA.
Email: snehithakasu@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- DOI:
- 10.5530/jppcm.20260006
How to cite
Shaik, F. A., Kasu, S., Jonnadula, K., Ganjala, H., Manchikanti, H. S., Kota, S., & Valaparla, R. (2026). A Case Reports On Bilateral Diffuse Cystic Lung Disease (Pulmonary Langerhans’ Cell Histiocytosis). Journal of Pharmacy Practice and Community Medicine, 12(3), 191–195. https://doi.org/10.5530/jppcm.20260006
Abstract
Diffuse Cystic Lung Disease (DCLD) is an uncommon and complex condition marked by the presence of numerous air-filled cysts scattered throughout the lung tissue. This case report discusses about a 67-year-old man who came to the hospital with symptoms including nausea, vomiting, fever, persistent cough, and chest discomfort. His medical background was notable for rheumatoid arthritis, Hypothyroidism, Cholelithiasis, and Grade I Fatty Liver Infiltration, along with a history of undergoing coronary artery angiography. Imaging studies revealed a collapse and consolidation in the lower lobe of the left lung, alongside multiple cysts in both lungs and areas of ground-glass opacity. Blood tests indicated signs of inflammation and abnormalities in hematological and liver function parameters. Based on the clinical and radiological findings, a final diagnosis of bilateral DCLD Pulmonary langerhans cell histiocytosis, was made. The patient was managed with bronchodilators, corticosteroids, NSAID’s, analgesics, and antiemetics. This case underscores the diagnostic complexity and therapeutic challenges of DCLD, emphasizing the urgent need for more research to enhance early detection and improve treatment outcomes.
Keywords
Subject
Article metadata
| Title | A Case Reports On Bilateral Diffuse Cystic Lung Disease (Pulmonary Langerhans’ Cell Histiocytosis) |
|---|---|
| Authors | Faizan Ali Shaik; Snehitha Kasu; Kedareswari Jonnadula; Hemalatha Ganjala; Hima Sathwika Manchikanti; Sandhya Kota; Ramya Valaparla |
| Affiliations | Department of Pharmacy Practice, Pharmacology, Nirmala College of Pharmacy, Acharya Nagarjuna University, Atmakur, Mangalagiri, Guntur, Andhra Pradesh, INDIA. |
| Corresponding author | snehithakasu@gmail.com |
| Journal | Journal of Pharmacy Practice and Community Medicine |
| Volume / Issue | Vol. 12, Issue 3 (2026) |
Also in this issue
- A Translational Investigation Linking Pharmacological Mechanisms of Drug Toxicity to Clinical Safety Outcomes and Adverse Drug Reactionspp. 128–137
- Awareness, Attitudes, and Practices of Infection Control in Libya: A Mixed-Methods Studypp. 138–141
- Quality Improvement through NABH Accreditation: A Review of Strategies for Preventing Medication Errors in Hospitalspp. 142–147
- Psychotherapeutic Interventions for Anxiety Disorders: A Narrative Review of Mechanisms, Efficacy, and Implementation Barrierspp. 148–154
- Nanotechnology-Based Drug Delivery in Cancer and Neurological Disorderspp. 155–163